StemCyte Revenue
Biotechnology Research • 
508 忠孝東路七段, Nangang District, Taiwan, Province of China • 101-200 Employees
StemCyte revenue & valuation
| Annual revenue | $3,952,507 |
| Revenue per employee | $23,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $12,700,000 |
| Total funding | $8,800,000 |
Key Contacts at StemCyte
Company overview
| Headquarters | 508 忠孝東路七段, Nangang District, Taipei City 115, TW |
| Phone number | +886226013013 |
| Website | |
| NAICS | 541714 |
| SIC | 809 |
| Keywords | Private/Family Cord Blood And Cord Lining Storage, Public Donation Cord Blood Banking, Provide Unrelated Cord Blood Products |
| Founded | 1997 |
| Employees | 101-200 |
| Socials |
StemCyte Email Formats
StemCyte uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@stemcyte.com), used 52.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@stemcyte.com | 52.8% |
{first initial}{last name} | jdoe@stemcyte.com | 44.4% |
{last name} | doe@stemcyte.com | 2.8% |
About StemCyte
StemCyte is dedicated to expanding the applications of cell therapy to address currently incurable diseases, paving the way for a healthier future through its guiding principle: “Better Cell, Better Life.” Founded in the United States in 1997, StemCyte has established a strong presence in Taiwan and India. To date, it has built a public cord blood bank with over 36,000 units, making it the largest in scale globally, with unparalleled racial diversity and superior quality. StemCyte is also among the few biotechnology companies that operate both public and private cord blood banks. Over the past 20 years, StemCyte has provided more than 2,300 cord blood units to over 350 transplant centers worldwide, supporting the treatment of various diseases. In November 2024, StemCyte became the first private company in the world to obtain FDA approval for a cord blood biologics license. Moving forward, StemCyte will continue its commitment to advancing the development of cord blood cell therapies, ensuring that physicians and patients around the globe have access to safe and effective cell therapy resources. For more information, please visit https://stemcytebio.com/.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
StemCyte has 70 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore StemCyte's funding history, including investment rounds, total capital raised, and key backers.
StemCyte Tech Stack
Discover the technologies and tools that power StemCyte's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
WordPress plugins
Caching
JavaScript libraries
Page builders
CDN
Web servers
Miscellaneous
Security
Programming languages
Blogs
Finland
Australia
Belgium
Frequently asked questions
4.8
40,000 users
